X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

In-Person Meetings To Begin By The FDA Starting February 13

Content Team by Content Team
1st February 2023
in News

FDA has recently announced that it is going to restart its in-person meetings that are face-to-face beginning February 13 with industry sponsors of biologics and drugs. This step is taken after a shift took place toward all virtual meetings during the COVID-19 pandemic for almost three years.

That said, the agency also defined that it has revised the definition of such formal meetings to include both virtual as well as in-person elements, thereby utilising the IT platforms that aid in both audio as well as video interaction. The FDA says that the face-to-face between themselves and the industry is going to be a combination of both, in-person as well as virtual, with cameras in place.

The redefining of in-person meetings was agreed upon in the recently upgraded user-free agreements for drugs as well as biosimilars. The FDA is also looking to apply a similar process in formal meetings that involve over-the-counter medicines, although the new user fee agreement does not have this particular policy in place. As of now, the agency will limit the face-to-face sessions with hybrid components to encourage Type A meetings, Type X meetings, and Biosimilar Product Development Type 1 sessions. The other meeting types are going to be completely virtual, without any in-person element in them.

The FDA remarks that it is in the process of upgrading the guidance documents when it comes to formal meetings so as to include the revised definition and is also highlighting the new meeting policy across its website in order to help reduce the uncertainties for all the parties involved. This dual approach to in-person meetings is a reflection of the hybrid workplace format existing in the Centers for Drug Evaluation and Research as well as the Centers for Biologics Evaluation and Research. The agency is also upgrading its conference rooms over there in phases in order to better take care of hybrid meetings.

So as to better manage the in-person element of the hybrid sessions, the FDA also plans to limit the number of people present in the room to those with primary speaking roles, and it also encourages the entire industry to do so. Other staffers across the parties can join the session online. As FDA starts putting in place more conference rooms, it also plans to conduct other types of meetings when it comes to in-person scheduling like milestone meetings for Type A and Type B, Type X ad Type Y as well as BPD Type 1 and Type 2. Eventually, with time, all the FTF formal meetings may fall under the gamut of an in-person format.

Previous Post

Medicine Patient Pool For 2023-25 To Curb Drug Inequalities

Next Post

Drug Nod Delays Not Hampering South Korean Pharma Position

Related Posts

DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Drug Development

Advanced Instruments All Set To Merge With Nova Biomedical

22nd March 2025
Drug Development

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

21st March 2025
Clinical Trials

Oracle Wins the Asia Pacific Biopharma Excellence Awards

21st March 2025
Clinical Trials

Bio-Rad to Acquire Stilla Technologies by Q3 2025

28th February 2025
Next Post

Drug Nod Delays Not Hampering South Korean Pharma Position

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In